TY - JOUR T1 - Population eye health education using augmented reality and virtual reality: scalable tools during and beyond COVID-19 JF - BMJ Innovations JO - BMJ Innov SP - 278 LP - 283 DO - 10.1136/bmjinnov-2020-000522 VL - 7 IS - 2 AU - Dinesh Visva Gunasekeran AU - Rebecca Low AU - Ruvendren Gunasekeran AU - Benedict Chan AU - Hong Ya Ong AU - Dhananjay Raje AU - Helen Mi AU - Carlos Pavesio AU - Quan Dong Nguyen AU - Rupesh Agrawal Y1 - 2021/04/01 UR - http://innovations.bmj.com/content/7/2/278.abstract N2 - Summary boxWhat is already known?Immersive technology such as augmented reality (AR) and/or virtual reality (VR) could be applied for health promotion in a scalable manner.What are the new findings?This investigation highlights the potential role of immersive technology such as augmented reality (AR) and/or virtual reality (VR) for scalable health promotion.There were no safety issues encountered, and patients did not report any symptoms such as motion sickness with use of AR and/or VR.Patients had demonstrably improved understanding about glaucoma and the importance of eye screening after utilisation of these immersive tools for eye health.This can positively impact healthcare by improving patient understanding about the importance of screening if such solutions are made available when patients are waiting in primary care and/or ophthalmic clinic settings whereby busy practitioners may not have the bandwidth to discuss screening in detail.These can be made available in primary care and/or ophthalmic clinic waiting rooms, where busy practitioners may not have the bandwidth to discuss screening in detail.The COVID-19 outbreak has had a massive impact on healthcare systems, with over 12 million infected individuals as of 10 July 2020.1 This has necessitated operational overhaul in ophthalmology and other clinical specialties in accordance with public health measures such as physical distancing and cancellation of non-urgent clinical services.2 The downstream impact of these measures include the disruption of healthcare functions including preventive programmes such as eye screening, which serve a crucial role to detect disease at early stages before the onset of irreversible morbidity such as visual impairment (VI).VI is already a growing problem even in developed countries.3 By 2020, estimates show that 230 million individuals will be affected by VI,4 and that 20 million across Asia are already severely affected to the point of blindness.5 Studies have attributed an increased risk of death to VI6 7 … ER -